Hanmi Science Q1 2026: Net profit +73% YoY, Operating profit +24% YoY
-
Consolidated revenue: KRW 353.7B (+6.5% YoY, +2.8% QoQ)
-
Operating profit: KRW 33.6B (+24% YoY, -11.1% QoQ)
-
Pre-tax profit: KRW 45.3B (+70% YoY, +22% QoQ)
-
Net income: KRW 42.3B (+73% YoY, +27.9% QoQ)
-
Controlling interest net income: KRW 42.7B (+70.4% YoY, +32.4% QoQ)
-
No shareholder return items (no share buyback, cancellation, or dividends disclosed)
KOSPI Filing Information
-
Filing: Consolidated Financial Statements Basis Operating (Provisional) Results (Fair Disclosure)
-
Company: Hanmi Science (008930)
-
Submission: Hanmi Science Co.,Ltd
-
Receipt: 04-30-2026
-
Under KRX KOSPI Market Division